SCHEMBL3696112

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL16616578	0.87	APLNR (0.36)	APLNRCNR1CNR2DUTDHFR
	SCHEMBL16624370	0.84	PDIA6 (0.38)	DUT
	SCHEMBL16624375	0.80	MAPT (0.43)	DUT
	SCHEMBL3465581	0.80	APLNR (0.45)	APLNRCA2
	SCHEMBL3706778	0.79	PPARG (0.38)	CD274CNR1CNR2DHFR
	SCHEMBL8548095	0.79	PDCD1 (0.36)	PDCD1CD274APLNRCNR1CNR2
	SCHEMBL6119928	0.79	ALDH1A1 (0.52)	DUT
	SCHEMBL3705863	0.77	TLR7 (0.43)	DHFR
	SCHEMBL1629693	0.76	HRH3 (0.43)	DUTPDE4A
	SCHEMBL2016744	0.76	CNR2 (0.46)	PDCD1CD274APLNRCNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.